Moderna to provide business and pipeline updates at the 2023 j.p. morgan healthcare conference

Cambridge, ma / accesswire / january 3, 2023 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced that ceo stÉphane bancel will present an update on the company and its pipeline of mrna development programs at the 41st annual j.p. morgan healthcare conference on monday, january 9th at 5:15 p.m.
MRNA Ratings Summary
MRNA Quant Ranking